The crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up

The crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up Interest in GLP-1 medications like Ozempic will continue to grow given the multiple health conditions they can improve. Steve Christo—Corbis/Corbis via Getty Images